J.P. Morgan Private Wealth Advisors LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 304 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
J.P. Morgan Private Wealth Advisors LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$1,122,455
+1.5%
72,557
+3.0%
0.00%
-50.0%
Q2 2023$1,106,361
-11.2%
70,424
-6.8%
0.01%
+100.0%
Q1 2023$1,245,427
+23.0%
75,572
+16.4%
0.00%
+50.0%
Q4 2022$1,012,939
+11.7%
64,932
-7.2%
0.00%0.0%
Q3 2022$907,000
+13.7%
69,961
+23.1%
0.00%0.0%
Q2 2022$798,000
+11.8%
56,835
+14.0%
0.00%0.0%
Q1 2022$714,000
+49.1%
49,843
+41.8%
0.00%
+100.0%
Q4 2021$479,000
-2.4%
35,142
+17.1%
0.00%0.0%
Q3 2021$491,000
+36.4%
30,006
+40.4%
0.00%0.0%
Q2 2021$360,000
+68.2%
21,365
+96.6%
0.00%0.0%
Q4 2019$214,00010,8680.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2023
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders